Patent · US Active

Adenosine A2a receptor antagonists

USRE44205E1 · kind E1 · reissue

2Cited by
10References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 6, 2012
Grant dateMay 7, 2013
Priority date
Expiry dateApr 6, 2032

Classification

  • Technology area (CPC —)General

Abstract

Compounds having the structural formula Ior a pharmaceutically acceptable salt thereof, wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.